Gilead insider plans $415K sale of 3,000 shares

Gilead Sciences insider Andrew Dickinson filed a notice to sell 3,000 shares of common stock of GILD through Morgan Stanley Smith Barney LLC, with an aggregate market value of $415,080.00, expected on August 17, 2026.

Rhea-AI Filing Summary

Gilead Sciences insider Andrew Dickinson filed a notice to sell 3,000 shares of common stock of GILD through Morgan Stanley Smith Barney LLC, with an aggregate market value of $415,080.00, expected on August 17, 2026. The shares were acquired as Performance Shares on January 31, 2024. Dickinson previously sold 3,000 shares on June 15, 2026 for $376,200.00 and 3,000 shares on July 15, 2026 for $389,776.80.

Key Figures

Planned shares to be sold: 3,000 shares Aggregate market value: $415,080.00 Sale on 06/15/2026: 3,000 shares for $376,200.00 +3 more

6 metrics

Planned shares to be sold 3,000 shares Common stock proposed for sale on 08/17/2026

Aggregate market value $415,080.00 Market value of 3,000 shares in proposed 08/17/2026 sale

Sale on 06/15/2026 3,000 shares for $376,200.00 Common stock sold during past three months

Sale on 07/15/2026 3,000 shares for $389,776.80 Common stock sold during past three months

Acquisition date of shares 01/31/2024 Performance Shares from issuer to be sold under Form 144

Planned sale date 08/17/2026 Expected date of Form 144 sale on NASDAQ

Key Terms

Form 144, Performance Shares, aggregate market value

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Performance Shares financial

"Common | 01/31/2024 | Performance Shares | Issuer"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

aggregate market value financial

"3000 | 415080.00 | 1239955155 | 08/17/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Gilead Sciences’ (GILD) latest Form 144 filing disclose?

The filing discloses that Andrew Dickinson plans to sell 3,000 shares of Gilead common stock, with an aggregate market value of $415,080.00, through Morgan Stanley Smith Barney LLC on August 17, 2026.

How many GILD shares are covered by Andrew Dickinson’s new Form 144?

The notice covers a proposed sale of 3,000 shares of Gilead Sciences common stock. These shares were acquired as Performance Shares on January 31, 2024 and are planned to be sold on August 17, 2026 on NASDAQ.

What is the total market value of GILD shares in the proposed Form 144 sale?

The proposed sale involves an aggregate market value of $415,080.00 for 3,000 shares of Gilead common stock. This value reflects the market price used in the Form 144 notice for the planned NASDAQ transaction.

Which broker is handling Andrew Dickinson’s proposed GILD share sale?

The proposed sale of 3,000 Gilead (GILD) shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as disclosed in the Form 144.

What recent GILD stock sales has Andrew Dickinson reported in the past three months?

He reported selling 3,000 shares of Gilead common stock on June 15, 2026 for $376,200.00 and another 3,000 shares on July 15, 2026 for $389,776.80, as listed in the three-month sales section.

When were the GILD shares in the new Form 144 acquired and in what form?

The 3,000 shares covered by the new Form 144 were acquired on January 31, 2024 as Performance Shares from the issuer. This acquisition date and form are disclosed in the "Securities To Be Sold" section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:12 PM Accepted by SEC EDGAR 08/17/2026 - 04:11 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001310204
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GILEAD SCIENCES, INC.
SEC File Number	000-19731
Address of Issuer	333 Lakeside Drive Foster City CALIFORNIA 94404
Phone	(650) 574-3000
Name of Person for Whose Account the Securities are To Be Sold	ANDREW DICKINSON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	415080.00	1239955155	08/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2024	Performance Shares	Issuer			3000	01/31/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	07/15/2026	3000	389776.80
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	06/15/2026	3000	376200.00

144: Remarks and Signature

Remarks
Date of Notice	08/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/29/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andrew D Dickinson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)